blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2986599

EP2986599 - N-PIPERIDIN-3-YLBENZAMIDE DERIVATIVES FOR TREATING CARDIOVASCULAR DISEASES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.10.2018
Database last updated on 14.06.2024
FormerExamination is in progress
Status updated on  18.11.2016
Most recent event   Tooltip19.10.2018Application deemed to be withdrawnpublished on 21.11.2018  [2018/47]
Applicant(s)For all designated states
Pfizer Inc.
235 East 42nd Street
New York, NY 10017 / US
[2016/08]
Inventor(s)01 / DAROUT, Etzer
29 Maple Avenue
Apt. 2
Sharon, MA 02067 / US
02 / DULLEA, Robert
63 Fairway Drive
Groton, Massachusetts 01450 / US
03 / HAWKINS, Julie Jia Li
1 Grey Fox Lane
Weston, Connecticut 06883 / US
04 / LONDREGAN, Allyn T.
26 Chapel Road
Barrington, Rhode Island 02806 / US
05 / LORIA, Paula M.
13 Town Clerk Rd
Killingworth, Connecticut 06419 / US
06 / MAGUIRE, Bruce
17 Waterhouse Lane
Chester, Connecticut 06412 / US
07 / MCCLURE, Kim F.
12 Willow Drive
Mystic, Connecticut 06355 / US
08 / PETERSEN, Donna N.
107 Forsyth Road
Salem, Connecticut 06420 / US
09 / PIOTROWSKI, David W.
19 Beacon Hill Drive
Waterford, Connecticut 06385 / US
 [2016/22]
Former [2016/14]01 / DAROUT, Etzer
29 Maple Avenue
Apt. 2
Sharon, MA 02067 / US
02 / DULLEA, Robert
63 Fairway Drive
Groton, Massachusetts 01450 / US
03 / HAWKINS, Julie Jia Li
1 Grey Fox Lane
Weston, Connecticut 06883 / US
04 / LONDREGAN, Allyn T.
26 Chapel Road
Barrington, Rhode Island 02806 / US
05 / LORIA, Paula M.
38 River Road
Killingworth, Connecticut 06419 / US
06 / MAGUIRE, Bruce
17 Waterhouse Lane
Chester, Connecticut 06412 / US
07 / MCCLURE, Kim F.
12 Willow Drive
Mystic, Connecticut 06355 / US
08 / PETERSEN, Donna N.
107 Forsyth Road
Salem, Connecticut 06420 / US
09 / PIOTROWSKI, David W.
19 Beacon Hill Drive
Waterford, Connecticut 06385 / US
Former [2016/08]01 / DAROUT, Etzer
700 Huron Avenue
Apt. 2H
Cambridge, Massachusetts 02138 / US
02 / DULLEA, Robert
63 Fairway Drive
Groton, Massachusetts 01450 / US
03 / HAWKINS, Julie Jia Li
1 Grey Fox Lane
Weston, Connecticut 06883 / US
04 / LONDREGAN, Allyn T.
26 Chapel Road
Barrington, Rhode Island 02806 / US
05 / LORIA, Paula M.
38 River Road
Killingworth, Connecticut 06419 / US
06 / MAGUIRE, Bruce
17 Waterhouse Lane
Chester, Connecticut 06412 / US
07 / MCCLURE, Kim F.
12 Willow Drive
Mystic, Connecticut 06355 / US
08 / PETERSEN, Donna N.
107 Forsyth Road
Salem, Connecticut 06420 / US
09 / PIOTROWSKI, David W.
19 Beacon Hill Drive
Waterford, Connecticut 06385 / US
Representative(s)Pfizer
European Patent Department
23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
[2016/08]
Application number, filing date14718777.703.04.2014
[2016/08]
WO2014IB60407
Priority number, dateUS201361812864P17.04.2013         Original published format: US 201361812864 P
US201361880336P20.09.2013         Original published format: US 201361880336 P
US201361898667P01.11.2013         Original published format: US 201361898667 P
[2016/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014170786
Date:23.10.2014
Language:EN
[2014/43]
Type: A1 Application with search report 
No.:EP2986599
Date:24.02.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 23.10.2014 takes the place of the publication of the European patent application.
[2016/08]
Search report(s)International search report - published on:EP23.10.2014
ClassificationIPC:C07D401/14, C07D413/14, A61K31/4725, A61K31/519, C07D471/04, C07D487/04, A61P7/00
[2016/08]
CPC:
C07D401/14 (EP,RU,US); A61K31/519 (RU,US); A61K31/4545 (EP,RU,US);
A61K31/4725 (EP,RU,US); A61K45/06 (US); A61P13/12 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P3/00 (EP); A61P3/06 (EP); A61P3/10 (EP);
A61P43/00 (EP); A61P7/00 (EP); A61P7/02 (EP);
A61P9/00 (EP); A61P9/04 (EP); A61P9/10 (EP);
C07D413/14 (EP,RU,US); C07D471/04 (EP,RU,US); C07D487/04 (EP,RU,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/08]
TitleGerman:N-PIPERIDIN-3-YLBENZAMID-DERIVATE ZUR BEHANDLUNG VON HERZ-KREISLAUF-ERKRANKUNGEN[2016/08]
English:N-PIPERIDIN-3-YLBENZAMIDE DERIVATIVES FOR TREATING CARDIOVASCULAR DISEASES[2016/08]
French:DÉRIVÉS DE N-PIPÉRIDIN-3-YLBENZAMIDE DANS LE TRAITEMENT DES MALADIES CARDIOVASCULAIRES[2016/08]
Entry into regional phase17.11.2015National basic fee paid 
17.11.2015Designation fee(s) paid 
17.11.2015Examination fee paid 
Examination procedure28.09.2015Amendment by applicant (claims and/or description)
17.11.2015Examination requested  [2016/08]
18.11.2016Despatch of a communication from the examining division (Time limit: M06)
17.05.2017Reply to a communication from the examining division
09.02.2018Despatch of a communication from the examining division (Time limit: M04)
20.06.2018Application deemed to be withdrawn, date of legal effect  [2018/47]
13.07.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2018/47]
Fees paidRenewal fee
02.05.2016Renewal fee patent year 03
02.05.2017Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.04.201805   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2009072649  (DAINIPPON SUMITOMO PHARMA CO [JP], et al) [A] 1-44 * Formula (I);; example 58; claim - *;
 [XA]WO2011051961  (CADILA HEALTHCARE LTD [IN], et al) [X] 22-34 * example -; claim - * [A] 1-21,35-44;
 [X]  - SEIDAH NABIL G, "PCSK9 as a therapeutic target of dyslipidemia", EXPERT OPINION ON THERAPEUTIC TARGETS, ASHLEY PUBLICATIONS, LONDON, GB, (20090101), vol. 13, no. 1, doi:10.1517/14728220802600715, ISSN 1472-8222, pages 19 - 28, XP008101389 [X] 22-34 * Paragraph 2.1 *

DOI:   http://dx.doi.org/10.1517/14728220802600715
by applicantHU151865
 CZ128471
 SE168308
 DD55956
 BE639386
 JPS485585B
 US2161938
 US2357985
 US2500444
 AT168063B
 DE860217
 US2661372
 US2661373
 DE905738
 FR1103113
 GB740932
 US2769015
 US2783241
 GB769757
 US2809194
 US2816118
 GB795174
 GB803372
 SU115905
 GB807826
 US2882271
 GB824547
 US2937169
 BE587225
 GB851287
 GB856409
 US2965655
 US2965656
 US2970082
 GB861367
 GB862248
 US2976289
 DE1102973
 DE1102750
 US2980699
 US2980679
 US3009911
 US3010965
 US3012042
 GB885078
 US3055904
 US3056836
 US3058882
 GB909357
 BE620829
 US3072653
 CH366523
 US3081230
 US3108097
 US3119826
 FR1365504
 US3152173
 FR2790M
 US3160641
 US3164588
 FR1390056
 GB984810
 US3183243
 US3188329
 US3228943
 FR1460571
 GB1025578
 US3254076
 US3255241
 US3261859
 US3262977
 US3262852
 US3265573
 US3267104
 US3267103
 NL6605692
 US3282938
 US3299067
 US3309406
 US3334096
 GB1077603
 US3337628
 US3338899
 US3350400
 US3355463
 US3356692
 US3360518
 US3371014
 DE1265758
 US3384642
 US3399192
 US3408387
 US3422107
 CH469002
 US3432545
 CH472404
 US3459756
 GB1160925
 BE730345
 DE1910481
 US3485847
 US3501769
 US3509164
 US3511836
 US3520919
 US3527761
 US3532685
 DE2020464
 US3542870
 US3551493
 US3563997
 US3565911
 US3567777
 US3634583
 US3655663
 US3663607
 US3663570
 US3663597
 US3665002
 US3669968
 DE2213044
 US3723476
 US3758506
 US3770724
 US3773939
 DE2240599
 US3799934
 US3818021
 US3819702
 US3836671
 DE2334404
 US3850941
 US3853923
 US3857952
 US3857981
 US3870720
 US3873600
 US3895030
 US3910924
 US3929836
 US3932400
 US3935267
 US3935259
 US3940489
 DE2521113
 US3961071
 US3960891
 US3962238
 US3983140
 US3985758
 US3997666
 US4010273
 US4012444
 US4018824
 US4018890
 US4018929
 US4034009
 US4035750
 US4038313
 US4045482
 US4046889
 US4059622
 US4062950
 DE2728641
 US4105776
 US4129565
 US4146643
 US4154839
 US4171370
 US4174439
 US4188390
 US4189438
 US4217305
 US4217307
 US4220649
 US4231938
 US4242453
 US4248883
 US4252984
 US4252825
 US4252721
 US4254256
 USRE30577E
 US4264611
 US4273765
 EP0041491
 US4337201
 US4338322
 US4340541
 US4344949
 US4346227
 BE893553
 US4374829
 US4385051
 US4394382
 US4405644
 US4410520
 US4444784
 EP0106275
 US4448784
 US4450171
 US4451455
 US4452813
 US4452790
 US4452811
 US4463176
 US4466972
 US4470972
 US4503067
 US4508727
 US4508729
 US4555502
 US4567175
 US4572909
 US4587258
 US4598089
 US4623714
 US4634765
 US4639436
 US4654362
 US4663325
 US4672068
 US4678783
 US4692464
 US4699905
 US4701559
 US4703063
 US4705797
 US4739073
 US4786635
 US4801599
 US4804770
 US4808605
 US4847271
 US4879303
 US4885284
 US4892875
 EP0363934
 US4933361
 US4952592
 EP0395768
 US5011930
 US5011859
 US5026554
 US5041432
 US5051534
 US5064856
 US5064864
 US5084461
 EP0468434
 US5091524
 US5102915
 US5120729
 EP0491226
 US5138069
 US5157116
 US5185351
 US5192772
 US5196444
 WO9312069
 US5270317
 US5273995
 US5274143
 WO9400480
 US5278171
 WO9401404
 FR2697250
 WO9410150
 EP0304063
 US5391571
 US5399578
 US5420305
 US5502199
 US5504078
 WO9610559
 US5510379
 US5512548
 US5512565
 JPH08143457
 US5540917
 WO9626948
 EP0738510
 WO9639384
 WO9639385
 WO9640640
 US5602151
 US5643874
 US5728704
 WO9823593
 US5866578
 US6140343
 US6197786
 USRE37314E
 WO02064549
 WO02064130
 US6579879
 US2003225158
 US6723752
    - HALEBLIAN, J PHARM SCI, (197508), vol. 64, no. 8, pages 1269 - 1288
    - LOUIS F. FIESER; MARY FIESER, Reagents for Organic Synthesis, WILEY, vol. 1-19
    - Beilsteins Handbuch der organischen Chemie, 4, Aufl., SPRINGER-VERLAG, vol. 4
    - LOPEZ-RODRIGUEZ; MARIA L., BIOORG. MED. CHEM., (2004), vol. 12, pages 5181 - 5184
    - BILODEAU, MARK T. ET AL., ORG. LETT., (2002), pages 3127 - 3129
    - LONDREGAN, ALLYN ET AL., ORG. LETT., (2011), pages 1840 - 1843
    - LAUDER ET AL., J. AM. CHEM. SOC., vol. 39, pages 659 - 68
    - ST. MAURICE ET AL., BIOCHEM., vol. 43, pages 2524 - 2532
    - LOPEZ-RODRIGUEZ; MARIA L. ET AL., BIOORG. MED. CHEM., (2004), vol. 12, pages 5181 - 5184
    - ROH ET AL., EUR. J. ORG. CHEM., (2012), pages 6101 - 6118
    - CHARTON, J. ET AL., TETRAHEDRON LETT., (2007), pages 1479 - 1483
    - METH. ENZYMOL., (1981), vol. 71, pages 455 - 509
    - METH ENZYMOL., (1975), vol. 35, pages 155 - 160
    - METH. ENZYMOL., (1985), vol. 110, pages 19 - 26
    - METH. ENZYMOL., (1985), vol. 110, pages 9 - 19
    - E.I. MERCER, PROG.LIP. RES., (1993), vol. 32, pages 357 - 416
    - J. ANTIBIOT., (1996), vol. 49, no. 8, pages 815 - 816
    - BIOORG. MED. CHEM. LETT., (1996), vol. 6, pages 1951 - 1954
    - WETTERAU, J. R., SCIENCE, (1992), vol. 258, page 999
    - METH. ENZYMOL., (1969), vol. 15, pages 393 - 454
    - METH. ENZYMOL., (1985), vol. 110, pages 359 - 373
    - CURR. OP. THER. PATENTS, (1993), pages 861 - 4
    - BIOCHIM. BIOPHYS. ACTA, (1984), vol. 794, pages 466 - 471
    - FEBS LETT., (1989), vol. 244, pages 347 - 350
    - J. LIPID RES., (1993), vol. 34, pages 377 - 395
    - HEIDER ET AL., JOURNAL OF LIPID RESEARCH., (1983), vol. 24, page 1127
    - METHODS ENZYMOL., vol. 286, pages 190 - 231
    - C.K. ABRAMS ET AL., GASTROENTEROLOGY, (1987), vol. 92, page 125
    - PETERSEN ET AL., LIEBIG'S ANNALEN, (1949), vol. 562, pages 205 - 229
    - KITAHARA ET AL., J. ANTIBIOTICS, (1987), vol. 40, no. 11, pages 1647 - 1650
    - UMEZAWA ET AL., J. ANTIBIOTICS, (1980), vol. 33, pages 1594 - 1596
    - J. MED. CHEM., (1998), vol. 41, pages 2934 - 2938
    - J. MALONE, DIABETES, (1980), vol. 29, pages 861 - 864
    - ANALYT. BIOCHEM, (2000), vol. 280, pages 329 - 331
    - BIOCHEMISTRY, (1969), vol. 8, page 4214
    - METHODS ENZYMOL., (1955), vol. 1, page 149
    - CLIFTON ET AL., JOURNAL OF MEDICINAL CHEMISTRY, (1982), vol. 25, page 670
    - SEEMAN ET AL., HELV. CHIM. ACTA, (1971), vol. 54, page 241
    - ULOTH ET AL., JOURNAL OF MEDICINAL CHEMISTRY, (1966), vol. 9, page 88
    - KENNEDY ET AL., JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (1955), vol. 77, page 250
    - KENNEDY, JOURNAL OF BIOLOGICAL CHEMISTRY, (1956), vol. 222, page 185
    - HERMANN ET AL., JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (1979), vol. 101, page 1540
    - BLICKE ET AL., JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (1942), vol. 64, page 1722
    - GOLDBERG, CHEM. PROD. CHEM. NEWS, (1954), vol. 17, page 371
    - J. CHEM. SOC., (1958), page 2426
    - BAXTER ET AL., JOURNAL OF THE CHEMICAL SOCIETY, (1949), page 30
    - CORRIGAN ET AL., JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (1945), vol. 67, page 1894
    - WALTER ET AL., JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (1941), vol. 63, page 2771
    - HAMBURG ET AL., ARCH. BIOCHEM. BIOPHYS., (1958), vol. 76, page 252
    - BADGETT ET AL., JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (1947), vol. 69, page 2907
    - BIOCHEM. BIOPHYS. RES. COMMUN., (1961), vol. 6, page 210
    - BUDAVERI,, Merck Index, Twelfth Edition,, (1996), page 1353
    - KORBONITS ET AL., ACTA. PHARM. HUNG., (1968), vol. 38, page 98
    - TSCHITSCHIBABIN, ANNALEN, (1930), vol. 479, page 303
    - FREUDENBERG ET AL., BER, (1957), vol. 90, page 957
    - MCMANUS ET AL., "136th Am. Soc. Meeting (Atlantic City", ABSTRACT OF PAPERS, (195909), pages 13 - 0
    - CLOSE ET AL., JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (1960), vol. 82, page 1132
    - DESTEVENS ET AL., EXPERIENTIA, (1960), vol. 16, page 113
    - OLIVIER, REC. TRAV. CHIM., (1918), vol. 37, page 307
    - ARTERIOSCLER THROMB VASC BIOL, (2012), vol. 32, pages 1585 - 1595
    - "Cell-Free Protein Synthesis Systems with Extracts from Cultured Human Cells", S. MIKAMI; T. KOBAYASHI; H. IMATAKA ET AL., Methods in Molecular Biology, HUMANA PRESS, (2010), vol. 607, pages 43 - 52
    - CHEN ET AL., J PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, (2001), vol. 26, page 63
 US20030720942
 US20040552114
 US20040807838
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.